Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Hedge Funds-News

Syneron Medical Ltd. (ELOS): Craig Drill Capital Boosts Its Stake to 5.17%

Published on October 19, 2016 at 11:17 am by Insider Monkey Staff in Hedge Funds, News

Craig Drill Capital‘s stake in Syneron Medical Ltd. (NASDAQ:ELOS) has gone up according to a new 13G filing with the SEC. Managed by Craig A. Drill, the fund’s holding of the stock stood at 160,000 Ordinary Shares at the end of the June quarter and has now climbed to 1.82 million Ordinary Shares or 5.17% of Syneron Medical’s outstanding stock.

Syneron Medical Ltd. (NASDAQ:ELOS) is a company that produces various products for the medical aesthetic industry. Since the beginning of the year, the company’s stock has lost 1.43%. In its financial report for the second quarter of 2016, Syneron Medical disclosed revenue of $74.97 million and EPS of $0.03, compared to revenue of $73.51 million, and a loss per share of $0.01 for the same period of the previous year. Recently, the company announced its preliminary financial results for the third quarter, with it announcing that revenue should reach $70 million-to-$72 million; its complete results are scheduled for release on November 9.

ATeam/Shutterstock.com

ATeam/Shutterstock.com

At the end of June, 14 smart money managers from within our database were long Syneron Medical Ltd. (NASDAQ:ELOS), same as a quarter earlier. Among the bullish investors were Richard Mashaal’s RIMA Senvest Management, which held $29.56 million worth of Syneron Medical’s shares, Conan Laughlin’s North Tide Capital, with a position valued at $26.92 million, Stephen Dubois’ Camber Capital Management, Jim Simons’ Renaissance Technologies, and Chuck Royce’s Royce & Associates.

Follow Syneron Medical Ltd. (NASDAQ:ELOS)

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Craig A. Drill 0 1,822,000 0 1,822,000 1,822,000 5.17%
Craig Drill Capital 0 1,822,000 0 1,822,000 1,822,000 5.17%
Craig Drill Capital 0 1,280,600 0 1,280,600 1,280,600 3.63%
Craig Drill Capital II 0 541,400 0 541,400 541,400 1.53%

Follow Craig A. Drill's Craig Drill Capital

Page 1 of 11 – SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No.)*
Syneron Medical Ltd.
(Name of Issuer)
Ordinary Shares, par value NIS 0.01Per Share
(Title of Class of Securities)
M87245102
(CUSIP Number)
October 17, 2016
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
[_]  Rule 13d-1(b)
[X]  Rule 13d-1(c)
[_]  Rule 13d-1(d)
__________
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Follow Syneron Medical Ltd. (NASDAQ:ELOS)

Page 2 of 11 – SEC Filing

CUSIP No
M87245102
1.
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Craig A. Drill
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)  [_]
(b)  [X]
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
1,822,000
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
1,822,000
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,822,000
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
 SHARES (SEE INSTRUCTIONS)
[_]
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.17%
12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN

Follow Syneron Medical Ltd. (NASDAQ:ELOS)

Page 3 of 11 – SEC Filing

CUSIP No
M87245102
1.
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Craig Drill Capital, L.L.C.
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)  [_]
(b)  [X]
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
1,822,000
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
1,822,000
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,822,000
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
 SHARES (SEE INSTRUCTIONS)
[_]
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.17%
12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IA

Follow Syneron Medical Ltd. (NASDAQ:ELOS)

Page 4 of 11 – SEC Filing

CUSIP No
M87245102
1.
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Craig Drill Capital, L.P.
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)  [_]
(b)  [X]
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
1,280,600
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
1,280,600
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,280,600
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
 SHARES (SEE INSTRUCTIONS)
[_]
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
3.63%
12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN

Follow Syneron Medical Ltd. (NASDAQ:ELOS)

Page 5 of 11 – SEC Filing

CUSIP No
M87245102
1.
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Craig Drill Capital II, L.P.
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)  [_]
(b)  [X]
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
541,400
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
541,400
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
541,400
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
 SHARES (SEE INSTRUCTIONS)
[_]
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
1.53%
12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN

Follow Syneron Medical Ltd. (NASDAQ:ELOS)

Page 6 of 11 – SEC Filing

CUSIP No
M87245102
Item 1.
(a).
Name of Issuer:
Syneron Medical Ltd.
(b).
Address of Issuer’s Principal Executive Offices:
Industrial Zone, Yokneam Illit, 20692, Tavor Building P.O.B. 550, Israel
Item 2.
(a).
Name of Person Filing:
Craig A. Drill
Craig Drill Capital, L.L.C.
Craig Drill Capital, L.P.
Craig Drill Capital II, L.P.
(b).
Address of Principal Business Office, or if None, Residence:
Craig A. Drill
c/o Craig Drill Capital, L.L.C.
724 Fifth Avenue
9th Floor
New York, New York 10019
Craig Drill Capital, L.L.C.
724 Fifth Avenue
9th Floor
New York, New York 10019
Craig Drill Capital, L.P.
c/o Craig Drill Capital, LLC
724 Fifth Avenue
9th Floor
New York, New York 10019
Craig Drill Capital II, L.P.
c/o Craig Drill Capital, LLC
724 Fifth Avenue
9th Floor
New York, New York 10019

Follow Syneron Medical Ltd. (NASDAQ:ELOS)

Page 7 of 11 – SEC Filing

(c).
Citizenship:
Craig A. Drill – United States of America
Craig Drill Capital, L.L.C. – Delaware
Craig Drill Capital, L.P. – Delaware
Craig Drill Capital II, L.P. – Delaware
(d).
Title of Class of Securities:
Ordinary Shares, par value NIS 0.01Per Share
(e).
CUSIP Number:
M87245102
Item 3.
If This Statement is filed pursuant to ss.240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a
(a)
[_]
Broker or dealer registered under Section 15 of the Exchange Act (15 U.S.C. 78c).
(b)
[_]
Bank as defined in Section 3(a)(6) of the Exchange Act (15 U.S.C. 78c).
(c)
[_]
Insurance company as defined in Section 3(a)(19) of the Exchange Act (15 U.S.C. 78c).
(d)
[_]
Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e)
[_]
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
[_]
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
[_]
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
(h)
[_]
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);
(i)
[_]
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
[_]
Group, in accordance with s.240.13d-1(b)(1)(ii)(J).

Follow Syneron Medical Ltd. (NASDAQ:ELOS)

Page 8 of 11 – SEC Filing

Item 4.
Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a)
Amount beneficially owned:
Craig A. Drill: 1,822,000
Craig Drill Capital, LLC: 1,822,000
Craig Drill Capital, L.P.: 1,280,600
Craig Drill Capital II, L.P.: 541,400
(b)
Percent of class:
Craig A. Drill: 5.17%
Craig Drill Capital, LLC: 5.17%
Craig Drill Capital, L.P.: 3.63%
Craig Drill Capital II, L.P.: 1.53%
(c)
Number of shares as to which Craig A. Drill:
(i)
Sole power to vote or to direct the vote
0
,
(ii)
Shared power to vote or to direct the vote
1,822,000
,
(iii)
Sole power to dispose or to direct the disposition of
0
,
(iv)
Shared power to dispose or to direct the disposition of
1,822,000
.
Number of shares as to which Craig Drill Capital, LLC has:
(i)
Sole power to vote or to direct the vote
0
,
(ii)
Shared power to vote or to direct the vote
1,822,000
,
(iii)
Sole power to dispose or to direct the disposition of
0
,
(iv)
Shared power to dispose or to direct the disposition of
1,822,000
.
Number of shares as to which Craig Drill Capital, L.P. has:
(i)
Sole power to vote or to direct the vote
0
,
(ii)
Shared power to vote or to direct the vote
1,822,000
,
(iii)
Sole power to dispose or to direct the disposition of
0
,
(iv)
Shared power to dispose or to direct the disposition of
1,822,000
.

Follow Syneron Medical Ltd. (NASDAQ:ELOS)

Page 9 of 11 – SEC Filing

Item 5.
Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].
N/A
Item 6.
Ownership of More Than Five Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than five percent of the class, such person should be identified.  A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
N/A
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary.  If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
N/A
Item 8.
Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group.  If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
N/A
Item 9.
Notice of Dissolution of Group.
Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity.  See Item 5.
N/A
Item 10.
Certification.
(a)
The following certification shall be included if the statement is filed pursuant to §240.13d-1(b).
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
(b)
The following certification shall be included if the statement is filed pursuant to §240.13d-1(b)(1)(ii)(J), or if the statement is filed pursuant to §240.13d-1(b)(1)(ii)(K) and a member of the group is a non-U.S. institution eligible to file pursuant to §240.13d-1(b)(1)(ii)(J):
By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to [insert particular category of institutional investor] is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s).  I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.
(c)
The following certification shall be included if the statement is filed pursuant to §240.13d-1(c):
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Follow Syneron Medical Ltd. (NASDAQ:ELOS)

Page 10 of 11 – SEC Filing

SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
October 17, 2016
Date
CRAIG A. DRILL *
By:  /s/ Craig A. Drill
Name: Craig A. Drill
Title: Managing Member
CRAIG DRILL CAPITAL, LLC.*
By:  /s/ Craig A. Drill
Name: Craig A. Drill
Title: Managing Member
CRAIG DRILL CAPITAL, L.P.
By:  /s/ Craig A. Drill
Name: Craig A. Drill
Title: Managing Member
CRAIG DRILL CAPITAL II, L.P.
By:  /s/ Craig A. Drill
Name: Craig A. Drill
Title: Managing Member
*The Reporting Persons disclaim beneficial ownership over the securities reported herein except to the extent of the Reporting Persons’ pecuniary interest therein.
The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative.  If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference.  The name and any title of each person who signs the statement shall be typed or printed beneath his signature.
Note.  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See s.240.13d-7 for other parties for whom copies are to be sent.
Attention.  Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).

Follow Syneron Medical Ltd. (NASDAQ:ELOS)

Page 11 of 11 – SEC Filing

EXHIBIT A
AGREEMENT
The undersigned agree that this Schedule 13G dated October 17, 2016 relating to the Ordinary Shares, par value NIS 0.01Per Share of Syneron Medical Ltd. shall be filed on behalf of the undersigned.
CRAIG A. DRILL
By:  /s/ Craig A. Drill
Name: Craig A. Drill
Title: Managing Member
CRAIG DRILL CAPITAL, LLC
By:  /s/ Craig A. Drill
Name: Craig A. Drill
Title: Managing Member
CRAIG DRILL CAPITAL, L.P.*
By:  /s/ Craig A. Drill
Name: Craig A. Drill
Title: Managing Member
CRAIG DRILL CAPITAL II, L.P.*
By:  /s/ Craig A. Drill
Name: Craig A. Drill
Title: Managing Member

Follow Syneron Medical Ltd. (NASDAQ:ELOS)

Show more...Show less

Related Insider Monkey Articles
Here's Why Zynerba Pharmaceuticals, Kratos Defense, Rogers Communications,...Bellatrix Exploration Ltd. (BXE): Billionaire Howard Marks' Oaktree Capital...
News Corp (NWSA) Stock: International Value Advisers Lowers Its Class B Stake...Myokardia Inc (MYOK): Cormorant Asset Management Raises Its Stake
Independence Contract Drilling Inc. (ICD): Adage Capital Management Boosts...Gores Holdings Inc.(GRSH): Blue Mountain Capital Reports 1% Stake